How ‘New Science’ Is Changing Healthcare

If there’s one good thing that’s come from the pandemic, it’s this: Scientists and drug manufacturers came together in record time and with a shared purpose to create a safe and effective Covid-19 vaccine. In doing so, they set a precedent for medical advancements. So, where do we go from here? In this episode, we’ll talk about how biopharma companies can learn from last year’s disruption and harness what Accenture calls ‘New Science’ to rapidly discover and deliver revolutionary treatments and preparing for in the midst of regulatory and economic shifts. We’ll speak with Chris Gibson, C.E.O. and Co-Founder at Recursion; Stuart Henderson, Global Industry Lead — Life Sciences at Accenture; and David Coman, C.E.O at Science 37.

Om Podcasten

The modern business landscape is constantly evolving, presenting unprecedented challenges for leaders. The Built for Change podcast, hosted by journalist Elise Hu and technologist Josh Klein, explores these challenges and how leaders can adapt to thrive in this environment. Through insightful conversations with industry thought leaders, the podcast explores innovative approaches to meeting customer needs, the relationship between employee well-being and company success, and the role of technology and sustainability in driving business transformation. Whether you're a business leader seeking to stay ahead of the curve or simply interested in the latest developments in the world of business, Built for Change offers valuable insights and actionable advice. Subscribe to the podcast today and join the conversation on how to thrive in an ever-changing business landscape.